nilutamide — Medica
Prostate cancer
Initial criteria
- Diagnosis of prostate cancer
- Nilutamide is used concurrently with a luteinizing hormone-releasing hormone (LHRH) agonist (e.g., leuprolide, triptorelin, goserelin, histrelin)
Approval duration
1 year